# Gan & Lee Pharmaceuticals. (603087.SS): MoatMap facts

As of 4 Nov 2026. Research data, not investment advice.

As of 4 Nov 2026, MoatMap's StockRank for Gan & Lee Pharmaceuticals. (603087.SS) is 54/100, ranked against 24,000+ stocks in 35 markets (Quality 71, Value 29, Momentum 48, each scored against its sector).

- StockRank: 54/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 71, Value 29, Momentum 48: each a 0-100 percentile within Healthcare.
- Position: #12,164 overall, #1,127 in Healthcare.
- Listing: China, SHH; Healthcare / Medical Instruments & Supplies.
- Last close: 69.15 CNY on 3 Nov 2026.
- Insider filings, last 180 days: directors sold USD 7.3M.

Source: https://moatmap.ai/stock/603087.SS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker